DGAP-News: Cytos Biotechnology Ltd: Placebo-controlled phase II study shows CYT003-QbG10 is safe and efficacious for …

DGAP-News: Cytos Biotechnology Ltd: Placebo-controlled phase II study shows CYT003-QbG10 is safe and efficacious for …
Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement.

Read more on Financial.de

More Meth Drug Addiction Info:

• Maitsco Corporate Theme
• Shock & Awe Phase II: Germany to Ban Naked Short-Selling at …
• Placebo – Every You Every Me (song & lyrics) | Cash Profits
• Biotechnology: Changing Life Through Science 3-Volume Set | WebFeeder
• ZIOPHARM to Present Further Palifosfamide PICASSO Phase II Results …
• Thomas Associates – Staffing and Recruiting » Blog Archive …
• ! Tips Generex Biotechnology's Phase I study data of AE37 for …
• Placebo A Healthier Alternative to Anti-Depressants : Kevin …
• Obama in India from November 7 to 10 | Corporate News India and …
• Betting on Bilski: The Supreme Court and Biotechnology Patents